세계의 POC(Point-Of-Care) 혈당 검사 시장 보고서(2025년)

Point-of-care glucose testing denotes a quality-assured pathology service administered in close proximity to the patient rather than within the conventional confines of a clinical laboratory. Clinicians or individuals employ small handheld units or glucose analyzers, along with testing strips, for glucose testing on whole blood. This approach reduces the duration from specimen collection to result verification, leading to swifter therapeutic intervention, diminished preanalytical errors, and enhanced patient care.

The primary components in point-of-care glucose testing encompass lancet and lancing devices, strips, and meters. Lancets, small sharp instruments, puncture the skin to extract a small blood drop for testing, while lancing devices securely hold the lancet and are activated with a simple button push. These devices facilitate straightforward blood withdrawal and assessment of blood glucose levels using a blood glucose monitor and test strips in point-of-care glucose testing. Testing sites include fingertips and alternate site testing, applied in both type-1 and type-2 diabetes. Various end-users, such as professional diagnostic centers, hospitals and clinics, home care settings, among others, utilize these methods.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The point-of-care glucose testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care glucose testing market statistics, including point-of-care glucose testing industry global market size, regional shares, competitors with a point-of-care glucose testing market share, detailed point-of-care glucose testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care glucose testing industry. This point-of-care glucose testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care glucose testing market size has grown steadily in recent years. It will grow from $4.91 billion in 2024 to $5.14 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to growing prevalence of diabetes, increased awareness of diabetes management, expansion of the aging population, rise in healthcare infrastructure, adoption of point-of-care testing.

The point-of-care glucose testing market size is expected to see strong growth in the next few years. It will grow to $6.5 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to expansion of telemedicine services, growing emphasis on personalized medicine in diabetes care, rise in diabetes management programs, increased investment in glucose testing research and development, adoption of continuous glucose monitoring. Major trends in the forecast period include development of wearable glucose monitoring devices, integration of smartphone connectivity in glucose testing, growth of point-of-care testing in home healthcare settings, adoption of artificial intelligence in glucose data analysis, expansion of remote patient monitoring for diabetes.

The forecast of 6.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder diabetes management by inflating prices of continuous glucose monitors and test strip manufacturing equipment developed in Ireland and China, resulting in poorer glycemic control and higher endocrinology practice costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is expected to drive the growth of the point-of-care glucose testing market in the coming years. Diabetes is a chronic metabolic condition that raises blood glucose levels, leading to long-term complications, including severe damage to the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is widely used to monitor glucose levels in hospitalized patients, enabling quick treatment decisions in response to changes in glycemia and improving diabetes management and therapeutic outcomes. For example, in June 2024, according to NHS England, the number of individuals identified with pre-diabetes in England rose to 3,615,330 in 2023, an 18% increase from 3,065,825 in 2022. Moreover, cases among individuals under 40 surged by nearly 25%, from 173,166 in 2022 to 216,440 in 2023. Therefore, the rising prevalence of diabetes is fueling the growth of the point-of-care glucose testing market.

The growth of the point-of-care glucose testing market is further fueled by the rising aging population. As demographics shift toward an aging population, characterized by an increasing proportion of elderly individuals, point-of-care glucose testing becomes increasingly crucial. This technology serves essential purposes for older individuals, particularly those at higher risk of diabetes or already diagnosed. The World Health Organization projected that by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion, and by 2050, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion. Therefore, the growing aging population is a significant driver of the point-of-care glucose testing market.

Product innovation is a key trend gaining traction in the point-of-care glucose testing market, with major companies focused on developing innovative products. For instance, F. Hoffmann-La Roche AG introduced Cobas Pulse in January 2022, a new point-of-care blood glucose monitor designed for healthcare staff. This handheld device includes an automated glucose test strip reader, camera, and touchscreen, housed in a rugged casing that can be disinfected and used across all age groups, including newborns and intensive care patients. The innovation aims to enhance physicians' workflow by integrating Glucommander dosage software and offering downloadable decision-support apps.

Major companies in the point-of-care glucose testing market are also directing their efforts towards developing advanced solutions such as glucose-ketone monitoring sensors. Abbott Laboratories announced in June 2022 the development of a first-of-its-kind biowearable sensor system that continuously monitors glucose and ketones in diabetic patients. This breakthrough device, granted FDA designation, represents a significant advancement in regulatory status and is set to become the most compact and slender monitoring device globally. It integrates seamlessly with Abbott's digital ecosystem, allowing remote monitoring by healthcare professionals.

In August 2024, F. Hoffmann-La Roche AG, a healthcare company based in Switzerland, acquired Point of Care technology from LumiraDx Ltd. for an undisclosed sum. This acquisition enables Roche to enhance its diagnostics portfolio by incorporating a versatile platform that consolidates multiple tests into a single instrument, thereby supporting the growth of decentralized healthcare solutions. LumiraDx Ltd. is a UK-based company specializing in point-of-care diagnostics, particularly glucose testing solutions.

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

North America was the largest region in the point of care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care glucose testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care glucose testing market consists of revenues earned by entities by providing services such as diagnosis, monitoring, screening, and testing regimes to offer enhanced therapeutic intervention and patient care in lesser time. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care glucose testing market also includes sales of rapid assay dipsticks, glucose monitoring kits, and multifunctional benchtop devices which are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care Glucose Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care glucose testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care glucose testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care glucose testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Lancet And Lancing Devices; Strips; Meters
• 2) By Testing Site: Fingertips; Alternate Site Testing
• 3) By Applications: Type-1 Diabetes; Type-2 Diabetes
• 4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users
• Subsegments:
• 1) By Lancet And Lancing Devices: Single-Use Lancets; Multi-Use Lancets; Adjustable Lancing Devices
• 2) By Strips: Glucose Test Strips; Ketone Test Strips; Combo Strips (Glucose And Ketone)
• 3) By Meters: Blood Glucose Meters; Continuous Glucose Monitoring (CGM) Meters; Bluetooth-Enabled Meters
• Companies Mentioned: F Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Danaher Corporation; Siemens Healthineers; Becton, Dickinson and Company; TaiDoc Technology Corporation; B. Braun Melsungen AG; Beckman Coulter Inc.; Nipro Corporation; Dexcom Inc.; Bio-Rad Laboratories Inc.; LifeScan Inc.; Nova Biomedical Corporation; Ypsomed AG; Ascensia Diabetes Care Holdings AG; Trividia Health Inc.; Radiometer Medical ApS; HemoCue AB; EKF Diagnostics Holdings plc; Trinity Biotech plc; Bionime Corporation; PTS Diagnostics; ForaCare Inc.; Menarini Diagnostics; ACON Laboratories Inc.; Senseonics Holdings Inc.; Prodigy Diabetes Care LLC; Nemaura Medical Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care Glucose Testing Market Characteristics

3. Point-of-Care Glucose Testing Market Trends And Strategies

4. Point-of-Care Glucose Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point-of-Care Glucose Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Point-of-Care Glucose Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Point-of-Care Glucose Testing Market Growth Rate Analysis
• 5.4. Global Point-of-Care Glucose Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Point-of-Care Glucose Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Point-of-Care Glucose Testing Total Addressable Market (TAM)

6. Point-of-Care Glucose Testing Market Segmentation

• 6.1. Global Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lancet And Lancing Devices
• Strips
• Meters
• 6.2. Global Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fingertips
• Alternate Site Testing
• 6.3. Global Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type-1 Diabetes
• Type-2 Diabetes
• 6.4. Global Point-of-Care Glucose Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Professional Diagnostic Centers
• Hospitals And Clinics
• Home Care Settings
• Other End Users
• 6.5. Global Point-of-Care Glucose Testing Market, Sub-Segmentation Of Lancet And Lancing Devices, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Lancets
• Multi-Use Lancets
• Adjustable Lancing Devices
• 6.6. Global Point-of-Care Glucose Testing Market, Sub-Segmentation Of Strips, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucose Test Strips
• Ketone Test Strips
• Combo Strips (Glucose And Ketone)
• 6.7. Global Point-of-Care Glucose Testing Market, Sub-Segmentation Of Meters, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Glucose Meters
• Continuous Glucose Monitoring (CGM) Meters
• Bluetooth-Enabled Meters

7. Point-of-Care Glucose Testing Market Regional And Country Analysis

• 7.1. Global Point-of-Care Glucose Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Point-of-Care Glucose Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point-of-Care Glucose Testing Market

• 8.1. Asia-Pacific Point-of-Care Glucose Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point-of-Care Glucose Testing Market

• 9.1. China Point-of-Care Glucose Testing Market Overview
• 9.2. China Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point-of-Care Glucose Testing Market

• 10.1. India Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point-of-Care Glucose Testing Market

• 11.1. Japan Point-of-Care Glucose Testing Market Overview
• 11.2. Japan Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point-of-Care Glucose Testing Market

• 12.1. Australia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point-of-Care Glucose Testing Market

• 13.1. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point-of-Care Glucose Testing Market

• 14.1. South Korea Point-of-Care Glucose Testing Market Overview
• 14.2. South Korea Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point-of-Care Glucose Testing Market

• 15.1. Western Europe Point-of-Care Glucose Testing Market Overview
• 15.2. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point-of-Care Glucose Testing Market

• 16.1. UK Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point-of-Care Glucose Testing Market

• 17.1. Germany Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point-of-Care Glucose Testing Market

• 18.1. France Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point-of-Care Glucose Testing Market

• 19.1. Italy Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point-of-Care Glucose Testing Market

• 20.1. Spain Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point-of-Care Glucose Testing Market

• 21.1. Eastern Europe Point-of-Care Glucose Testing Market Overview
• 21.2. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point-of-Care Glucose Testing Market

• 22.1. Russia Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point-of-Care Glucose Testing Market

• 23.1. North America Point-of-Care Glucose Testing Market Overview
• 23.2. North America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point-of-Care Glucose Testing Market

• 24.1. USA Point-of-Care Glucose Testing Market Overview
• 24.2. USA Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point-of-Care Glucose Testing Market

• 25.1. Canada Point-of-Care Glucose Testing Market Overview
• 25.2. Canada Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point-of-Care Glucose Testing Market

• 26.1. South America Point-of-Care Glucose Testing Market Overview
• 26.2. South America Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point-of-Care Glucose Testing Market

• 27.1. Brazil Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point-of-Care Glucose Testing Market

• 28.1. Middle East Point-of-Care Glucose Testing Market Overview
• 28.2. Middle East Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point-of-Care Glucose Testing Market

• 29.1. Africa Point-of-Care Glucose Testing Market Overview
• 29.2. Africa Point-of-Care Glucose Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Point-of-Care Glucose Testing Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Point-of-Care Glucose Testing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point-of-Care Glucose Testing Market Competitive Landscape And Company Profiles

• 30.1. Point-of-Care Glucose Testing Market Competitive Landscape
• 30.2. Point-of-Care Glucose Testing Market Company Profiles
  • 30.2.1. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Point-of-Care Glucose Testing Market Other Major And Innovative Companies

• 31.1. TaiDoc Technology Corporation
• 31.2. B. Braun Melsungen AG
• 31.3. Beckman Coulter Inc.
• 31.4. Nipro Corporation
• 31.5. Dexcom Inc.
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. LifeScan Inc.
• 31.8. Nova Biomedical Corporation
• 31.9. Ypsomed AG
• 31.10. Ascensia Diabetes Care Holdings AG
• 31.11. Trividia Health Inc.
• 31.12. Radiometer Medical ApS
• 31.13. HemoCue AB
• 31.14. EKF Diagnostics Holdings plc
• 31.15. Trinity Biotech plc

32. Global Point-of-Care Glucose Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point-of-Care Glucose Testing Market

34. Recent Developments In The Point-of-Care Glucose Testing Market

35. Point-of-Care Glucose Testing Market High Potential Countries, Segments and Strategies

• 35.1 Point-of-Care Glucose Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Point-of-Care Glucose Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Point-of-Care Glucose Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer